Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approach.

Adult Aged Aged, 80 and over Case-Control Studies Cigarette Smoking / adverse effects Female Head and Neck Neoplasms / etiology Humans Male Middle Aged Risk Factors
Bivariate spline models Cigarette smoking duration Cigarette smoking intensity Head and neck cancer INHANCE Laryngeal cancer Oral cavity and pharyngeal cancers

Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
07 2019
Historique:
received: 12 10 2018
revised: 27 03 2019
accepted: 05 05 2019
entrez: 11 6 2019
pubmed: 11 6 2019
medline: 12 5 2020
Statut: ppublish

Résumé

This study aimed at re-evaluating the strength and shape of the dose-response relationship between the combined (or joint) effect of intensity and duration of cigarette smoking and the risk of head and neck cancer (HNC). We explored this issue considering bivariate spline models, where smoking intensity and duration were treated as interacting continuous exposures. We pooled individual-level data from 33 case-control studies (18,260 HNC cases and 29,844 controls) participating in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. In bivariate regression spline models, exposures to cigarette smoking intensity and duration (compared with never smokers) were modeled as a linear piecewise function within a logistic regression also including potential confounders. We jointly estimated the optimal knot locations and regression parameters within the Bayesian framework. For oral-cavity/pharyngeal (OCP) cancers, an odds ratio (OR) >5 was reached after 30 years in current smokers of ∼20 or more cigarettes/day. Patterns of OCP cancer risk in current smokers differed across strata of alcohol intensity. For laryngeal cancer, ORs >20 were found for current smokers of ≥20 cigarettes/day for ≥30  years. In former smokers who quit ≥10  years ago, the ORs were approximately halved for OCP cancers, and ∼1/3 for laryngeal cancer, as compared to the same levels of intensity and duration in current smokers. Referring to bivariate spline models, this study better quantified the joint effect of intensity and duration of cigarette smoking on HNC risk, further stressing the need of smoking cessation policies.

Identifiants

DOI: 10.1016/j.oraloncology.2019.05.006 PMID: 31178212 PMC: PMC7117823
pubmed: 31178212
pii: S1368-8375(19)30144-7
doi: 10.1016/j.oraloncology.2019.05.006
pmc: PMC7117823
mid: NIHMS1564386
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-57

Subventions

Organisme : NCI NIH HHS
ID : P01 CA068384
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA011386
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA030022
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES011740
Pays : United States
Organisme : FIC NIH HHS
ID : R03 TW001500
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE016631
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA100679
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA113157
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA100264
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA011979
Pays : United States
Organisme : NCI NIH HHS
ID : R13 CA210555
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE013158
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA078609
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA104231
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009142
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA096134
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA090731
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA077954
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES011667
Pays : United States
Organisme : NIDCR NIH HHS
ID : R03 DE016611
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA048996
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA090388
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE013110
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

Br J Cancer. 2012 Jul 24;107(3):406-7
pubmed: 22828655
Cancer Causes Control. 2013 Jun;24(6):1223-30
pubmed: 23553611
J Natl Cancer Inst. 2003 Dec 3;95(23):1772-83
pubmed: 14652239
Cancer Sci. 2006 Aug;97(8):760-7
pubmed: 16800818
Cancer Res. 1990 Oct 15;50(20):6502-7
pubmed: 2208109
Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):305-12
pubmed: 8348053
Am J Epidemiol. 2009 Oct 15;170(8):937-47
pubmed: 19745021
J Epidemiol Community Health. 2011 Aug;65(8):709-14
pubmed: 20724282
Laryngoscope. 1998 Jul;108(7):1098-103
pubmed: 9665264
Int J Cancer. 1998 Aug 31;77(5):705-9
pubmed: 9688303
J Natl Cancer Inst. 2009 Nov 18;101(22):1553-61
pubmed: 19917915
Br J Cancer. 2013 Nov 26;109(11):2904-10
pubmed: 24149181
Int J Cancer. 2004 Mar 1;108(6):907-11
pubmed: 14712496
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1188-93
pubmed: 15894670
Am J Epidemiol. 2013 Sep 1;178(5):679-90
pubmed: 23817919
Am J Epidemiol. 2007 Aug 15;166(4):479-89
pubmed: 17548786
Carcinogenesis. 2006 Jul;27(7):1432-44
pubmed: 16410261
Cancer Res. 2004 Jun 1;64(11):4049-54
pubmed: 15173020
Cancer Causes Control. 2011 Jul;22(7):1037-46
pubmed: 21607590
Int J Epidemiol. 2016 Jun;45(3):835-45
pubmed: 26228584
Oral Oncol. 2015 Aug;51(8):751-8
pubmed: 26094591
N Engl J Med. 2007 May 10;356(19):1944-56
pubmed: 17494927
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):696-703
pubmed: 16614111
Int J Cancer. 2008 May 15;122(10):2398-402
pubmed: 18224689
Am J Epidemiol. 2010 Jun 15;171(12):1250-61
pubmed: 20494999
Int J Cancer. 2006 Feb 1;118(3):714-20
pubmed: 16094634
Int J Epidemiol. 2010 Feb;39(1):182-96
pubmed: 19805488
J Natl Cancer Inst. 2007 May 16;99(10):777-89
pubmed: 17505073
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
pubmed: 15285078
Stat Med. 2010 Apr 30;29(9):1037-57
pubmed: 20087875
Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):476-82
pubmed: 15734975
BMC Public Health. 2011 Dec 14;11:928
pubmed: 22171573
Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1617-1631
pubmed: 27844225
Cancer Epidemiol Biomarkers Prev. 2000 Feb;9(2):185-91
pubmed: 10698480
Cancer Causes Control. 1999 Feb;10(1):27-33
pubmed: 10334639
Carcinogenesis. 2002 Jul;23(7):1229-34
pubmed: 12117782
Int J Epidemiol. 2004 Aug;33(4):799-806
pubmed: 15155704
Am J Epidemiol. 2014 Feb 1;179(3):290-8
pubmed: 24355332
Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):189-93
pubmed: 8318870
Eur J Epidemiol. 2016 Apr;31(4):385-93
pubmed: 25855002
Arch Otolaryngol Head Neck Surg. 2006 Nov;132(11):1231-6
pubmed: 17116820
Am J Epidemiol. 2001 Apr 15;153(8):807-14
pubmed: 11296155
J Clin Epidemiol. 2006 Jan;59(1):82-9
pubmed: 16360565
Int J Epidemiol. 2007 Feb;36(1):236-41
pubmed: 17510079
Cancer Res. 1996 Nov 15;56(22):5192-7
pubmed: 8912856
Br J Cancer. 2013 Mar 19;108(5):1218-20
pubmed: 23449359
Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1091-4
pubmed: 14578148
Eur J Cancer Prev. 2009 Feb;18(1):76-84
pubmed: 18830131
Cancer Res. 1978 Nov;38(11 Pt 1):3573-83
pubmed: 359124
BMC Cancer. 2009 May 08;9:137
pubmed: 19426493
Cancer Res. 1988 Jun 1;48(11):3282-7
pubmed: 3365707
Laryngoscope. 1997 Jun;107(6):765-81
pubmed: 9185733
Cancer Causes Control. 1990 Nov;1(3):235-41
pubmed: 2102296
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):541-50
pubmed: 19190158
Cancer Causes Control. 2010 Apr;21(4):567-75
pubmed: 20049634

Auteurs

Gioia Di Credico (G)

Department of Statistics, Padua University, Padua, Italy; Department of Economics, Business, Mathematics and Statistics, University of Trieste, Trieste, Italy.

Valeria Edefonti (V)

Branch of Medical Statistics, Biometry and Epidemiology "G. A. Maccacaro", Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy. Electronic address: valeria.edefonti@unimi.it.

Jerry Polesel (J)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

Francesco Pauli (F)

Department of Economics, Business, Mathematics and Statistics, University of Trieste, Trieste, Italy.

Nicola Torelli (N)

Department of Economics, Business, Mathematics and Statistics, University of Trieste, Trieste, Italy.

Diego Serraino (D)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

Eva Negri (E)

Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milano, Italy.

Daniele Luce (D)

Université de Rennes, INSERM, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, Pointe-à-Pitre, France.

Isabelle Stucker (I)

Inserm, Center for Research in Epidemiology and Population Health (CESP), Cancer and Environment team, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.

Keitaro Matsuo (K)

Aichi Cancer Center Research Institute, Nagoya, Japan.

Paul Brennan (P)

International Agency for Research on Cancer, Lyon, France.

Marta Vilensky (M)

Institute of Oncology Angel H. Roffo, University of Buenos Aires, Argentina.

Leticia Fernandez (L)

Institute of Oncology and Radiobiology, Havana, Cuba.

Maria Paula Curado (MP)

Epidemiology, CIPE/ACCAMARGO, Sao Paulo, Brazil.

Ana Menezes (A)

Universidade Federal de Pelotas, Pelotas, Brazil.

Alexander W Daudt (AW)

Hospital Moinhos de Vento, Porto Alegre, Brazil.

Rosalina Koifman (R)

Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil.

Victor Wunsch-Filho (V)

University of São Paulo School of Public Health, São Paulo, Brazil.

Ivana Holcatova (I)

Institute of Hygiene & Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

Wolfgang Ahrens (W)

Leibniz Institute for Prevention Research and Epidemiology, BIPS, Bremen, Germany; University of Bremen, Faculty of Mathematics and Computer Science, Bremen, Germany.

Pagona Lagiou (P)

Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Lorenzo Simonato (L)

Department of Cardiovascular and Thoracic Sciences and Public Health, University of Padova, Padova, Italy.

Lorenzo Richiardi (L)

Department of Medical Sciences, University of Turin, Turin, Italy.

Claire Healy (C)

Trinity College School of Dental Science, Dublin, Ireland.

Kristina Kjaerheim (K)

Cancer Registry of Norway, Oslo, Norway.

David I Conway (DI)

School of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow, UK.

Tatiana V Macfarlane (TV)

School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK and School of Medicine, University of Dundee, Dundee, UK.

Peter Thomson (P)

University of Hong Kong, Hong Kong, China.

Antonio Agudo (A)

Institut Catala Oncologia, Barcelona, Spain.

Ariana Znaor (A)

International Agency for Research on Cancer, Lyon, France.

Leonardo F Boaventura Rios (LF)

University of São Paulo School of Medicine, São Paulo, Brazil.

Tatiana N Toporcov (TN)

University of São Paulo School of Public Health, São Paulo, Brazil.

Silvia Franceschi (S)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

Rolando Herrero (R)

International Agency for Research on Cancer, Lyon, France.

Joshua Muscat (J)

Penn State College of Medicine, Hershey, PA, USA.

Andrew F Olshan (AF)

University of North Carolina School of Public Health, Chapel Hill, NC, USA.

Jose P Zevallos (JP)

Division of Head and Neck Surgical Oncology in the Department of Otolaryngology/Head and Neck Surgery at Washington University School of Medicine, USA.

Carlo La Vecchia (C)

Branch of Medical Statistics, Biometry and Epidemiology "G. A. Maccacaro", Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy.

Deborah M Winn (DM)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Erich M Sturgis (EM)

UT - M.D. Anderson Cancer Center, Houston, TX, USA.

Guojun Li (G)

UT - M.D. Anderson Cancer Center, Houston, TX, USA.

Eleonora Fabianova (E)

Regional Authority of Public Health in Banska Bystrica, Slovakia.

Jolanda Lissowska (J)

The M. Skasodowska-Curie Memorial Cancer Center and Institute of Oncology, Dept. of Cancer Epidemiology and Prevention, Warsaw, Poland.

Dana Mates (D)

National Institute of Public Health, Bucharest, Romania.

Peter Rudnai (P)

National Institute of Environmental Health to National Public Health Institute, Budapest, Hungary.

Oxana Shangina (O)

Cancer Research Centre, Moscow, Russia.

Beata Swiatkowska (B)

Institute of Occupational Medicine, Lodz, Poland.

Kirsten Moysich (K)

Roswell Park Cancer Institute, Buffalo, NY, USA.

Zuo-Feng Zhang (ZF)

UCLA School of Public Health, Los Angeles, CA, USA.

Hal Morgenstern (H)

Departments of Epidemiology and Environmental Health Sciences, School of Public Health and Department of Urology, Medical School, University of Michigan, Ann Arbor, MI, USA.

Fabio Levi (F)

Institut Universitaire de Medecine Sociale et Preventive (IUMSP), Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.

Elaine Smith (E)

College of Public Health, University of Iowa, Iowa City, IA, USA.

Philip Lazarus (P)

Washington State University College of Pharmacy and Pharmaceutical Sciences, Spokane, WA, USA.

Cristina Bosetti (C)

Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Werner Garavello (W)

Department of Otorhinolaryngology, School of Medicine and Surgery, University of Milano, Bicocca, Monza, Italy.

Karl Kelsey (K)

Brown University, Providence, RI, USA.

Michael McClean (M)

Boston University School of Public Health, Boston, MA, USA.

Heribert Ramroth (H)

University of Heidelberg, Germany.

Chu Chen (C)

Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Stephen M Schwartz (SM)

Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Thomas L Vaughan (TL)

Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Tongzhang Zheng (T)

Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA.

Gwenn Menvielle (G)

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Department of Social Epidemiology, F75012 Paris, France.

Stefania Boccia (S)

Department of Woman and Child Health and Public Health, Public Health Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Sezione di Igiene, Istituto di Sanità Pubblica, Università Cattolica del Sacro Cuore, Roma, Italy.

Gabriella Cadoni (G)

Dipartimento di Scienze dell'Invecchiamento, Neurologiche, Ortopediche e della Testa-Collo, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; Istituto di Clinica Otorinolaringoiatrica, Università Cattolica del Sacro Cuore, Roma, Italy.

Richard B Hayes (RB)

Division of Epidemiology, New York University School Of Medicine, New York, NY, USA.

Mark Purdue (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

Maura Gillison (M)

"Thoracic/Head and Neck Medical Oncology", The University of Texas MD Anderson Cancer Center, TX, USA.

Stimson Schantz (S)

New York Eye and Ear Infirmary, New York, NY, USA.

Guo-Pei Yu (GP)

Medical Informatics Center, Peking University, China.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Gypsyamber D'Souza (G)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Neil D Gross (ND)

Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Shu-Chun Chuang (SC)

Institute of Population Health Sciences, National Health Research Institutes, Taiwan.

Paolo Boffetta (P)

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Mia Hashibe (M)

Division of Public Health, Department of Family & Preventive Medicine and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.

Yuan-Chin Amy Lee (YA)

Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.

Luigino Dal Maso (L)

Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Joint effects of intensity and duration of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Joint effects of intensity and duration of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Joint effects of intensity and duration of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études cas-témoins › Joint effects of intensity and duration of...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Usage de tabac › Fumer du tabac › Fumer des cigarettes › Joint effects of intensity and duration of...
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Joint effects of intensity and duration of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Joint effects of intensity and duration of...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Joint effects of intensity and duration of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Joint effects of intensity and duration of...